▲ Bullish for Symbiotec Pharmalab

Symbiotec Pharmalab surges after Pithampur facility gets EIR from US FDA

1 source · first seen 11:16 29 Sept · updated 11:16 29 Sept

The brief

Written from 1 report · check the source before you trade

Symbiotec Pharmalab rose 5.56% to Rs 1115.50 after its Pithampur facility received a US FDA EIR
US FDA clearance strengthens Symbiotec Pharmalab’s regulatory standing; relevant to Indian pharma investors

Pick a tag to see all its stories

1 report · earliest 11:16